December 23, 2020
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
December 22, 2020
In December 2020, the U.S. FDA granted Emergency Use Authorization to Pfizer/BioNTech and Moderna for vaccines to prevent COVID-19 caused by SARS-CoV-2 infection. Moderna’s vaccine is indicated for use in individuals 18 and up
December 22, 2020
Adverse reactions or quality problems experienced with the use of a recalled product can be
reported to the FDA’s MedWatch Adverse Event Reporting
December 22, 2020
December 22, 2020 – The U.S. FDA has approved an expanded indication for Vaxchora® (cholera vaccine,
live) oral suspension, manufactured by Emergent Travel Health. The vaccine, which
December 21, 2020
December 21, 2020 – The U.S. FDA has approved expanded indications for three medications from Vertex
Pharmaceuticals that are indicated to treat cystic fibrosis (CF), with patients selected
December 14, 2020
December 14, 2020 – The U.S. FDA has approved an additional, shorter infusion time for Ocrevus®
(ocrelizumab). Manufactured by Roche, the drug is indicated to treat adults who have
December 14, 2020
December 14, 2020 – The U.S. FDA has granted Emergency Use Authorization (EUA) to a vaccine from Pfizer and BioNTech to prevent COVID-19 caused by the SARS-CoV-2 virus in individuals
December 11, 2020
December 11, 2020 - The U.S. Food and Drug Administration (FDA) granted Pfizer and BioNTech an
Emergency Use Authorization (EUA) for the companies’ jointly developed COVID-19 vaccine.